700251 | Taurocholic acid, sodium salt
5β-cholanic acid-3α,7α,12α-triol N-(2-sulphoethyl)-amide, sodium salt
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Taurocholic acid, sodium salt
5β-cholanic acid-3α,7α,12α-triol N-(2-sulphoethyl)-amide, sodium salt
Taurocholic Acid (TCA), also known as cholanic acid, cholyltaurine, taurocholate, or acidum chlatauricum, is a bile acid (BA), involved in the emulsification of fats. It’s one of the many physiological molecules in the body that have cholesterol as its precursor.
The compound occurs naturally as a sodium salt and is a major ingredient in the bile of mammals and carnivorous animals. It’s obtained through a process of conjugation of the primary BA cholic acid with the amino acid taurine. Cholic acid is one of the two main BAs in humans, along with chenodeoxycholic acid.
Taurocholic Acid is found to be a biomarker of the progression of liver cirrhosis and an active promoting factor. It most likely promotes liver cirrhosis by triggering hepatic stellate cells by stimulating the expression of TLR4 - a transmembrane protein, involved in a range of pathological responses and pathways in the body. Thus, recently, TCA has been investigated as a potential therapeutic target for the prevention and treatment of liver cirrhosis.
In addition, serum levels of the tauro-derivative are found to be decreased in Crohn's disease and ulcerative colitis with no extraintestinal manifestations. However, its concentrations are elevated in patients with ulcerative colitis combined with hepatobiliary disease.
Avanti Research manufactures quality and pure Taurocholic Acid for experimental bile acid analytical research.
C26H44NNaO7S
C 58.08%, H 8.25%, N 2.61%, Na 4.28%, O 20.83%, S 5.96%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by Bioz- Certificate of Analysis (Lot No. 700251P-10MG-A-010 and 6835PIA010)
- Certificate of Analysis (Lot No. 700251P-10MG-C-010 and 6835PIC010)
